-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on BioNTech, Lowers Price Target to $130

Benzinga·08/05/2026 14:08:58
Listen to the news
Evercore ISI Group analyst Cory Kasimov maintains BioNTech (NASDAQ:BNTX) with a Outperform and lowers the price target from $135 to $130.